Related Experiment Video
Updated: Sep 13, 2025

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Glyphosate targets FYN to regulate glycolysis and promote glioblastoma proliferation: A network toxicology study
Anquan Ma1, Ziqing Yang1, Qixuan He1
1Department of Prosthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan 250012, China.
Abstract:
Environmental glyphosate exposure has been linked to glioblastoma (GBM), yet its molecular basis remains unclear. Integrating network-toxicology and druggable Mendelian randomization screens, we identified the Src-family kinase FYN as the principal glyphosate target. Molecular-dynamics simulations, surface-plasmon resonance (KD = 1.54 μM) and pull-down assays confirmed high-affinity binding and highlighted ASP353 as a dominant contact residue. Multi-omics profiling showed FYN over-expression and promoter hypomethylation in GBM, correlating with diminished immune infiltration. In U87 cells, sub-toxic glyphosate (0.1 mg/L, 12 h) up-regulated FYN, activated PI3K-AKT-mTOR signaling, increased GLUT1, LDHA and PKM2, and accelerated proliferation, migration and invasion; lentiviral sh-FYN reversed these effects and curtailed glycolytic flux. Orthotopic mouse studies mirrored the in-vitro findings, with FYN knock-down suppressing glyphosate-driven tumor growth. Exosomes derived from sh-FYN glioma cells weakened macrophage M2 polarization and reduced CXCL1, IL-10 and TGF-β secretion, revealing an immunometabolism axis. Collectively, these results establish FYN as the mechanistic conduit between glyphosate and GBM and demonstrate that targeting FYN-directly or via exosome delivery-reprograms tumor glycolysis and immunity, offering a tractable strategy against glyphosate-associated malignancy.
Insights
Environmental glyphosate exposure is linked to glioblastoma (GBM). This study identifies FYN kinase as the key target, revealing a new strategy for treating GBM by targeting FYN or its related pathways.
Area of Science:
- Oncology
- Toxicology
- Molecular Biology
Background:
- Environmental glyphosate exposure is a suspected risk factor for glioblastoma (GBM).
- The precise molecular mechanisms linking glyphosate to GBM remain largely unknown.
- Understanding these links is crucial for developing effective cancer prevention and treatment strategies.
Purpose of the Study:
- To identify the molecular target of glyphosate relevant to glioblastoma.
- To elucidate the signaling pathways and cellular processes affected by glyphosate in GBM.
- To explore FYN kinase as a therapeutic target for glyphosate-induced GBM.
Main Methods:
- Network-toxicology and Mendelian randomization screens to identify glyphosate targets.
- Molecular-dynamics simulations, SPR, and pull-down assays to confirm FYN binding.
- Multi-omics profiling, cell-based assays (U87), and orthotopic mouse models to assess FYN's role in GBM.
- Exosome analysis to investigate immunometabolic effects.
Main Results:
- FYN (a Src-family kinase) was identified as the principal high-affinity glyphosate target.
- Glyphosate up-regulated FYN in GBM cells, activating PI3K-AKT-mTOR signaling and promoting tumor growth, migration, and invasion.
- FYN knockdown reversed glyphosate-induced effects and suppressed tumor growth in vivo.
- Targeting FYN modulated tumor glycolysis and reprogrammed the tumor immune microenvironment via exosomes.
Conclusions:
- FYN kinase is the mechanistic link between glyphosate exposure and glioblastoma development.
- Targeting FYN, directly or through exosome-mediated delivery, offers a promising therapeutic strategy for glyphosate-associated GBM.
- This research uncovers a novel immunometabolism axis in GBM driven by FYN signaling.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Negative Regulator Molecules